Have a feature idea you'd love to see implemented?
Let us know!
RXST RxSight Inc
Price (delayed)
$48.48
Market cap
$1.92B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.01
Enterprise value
$1.91B
Highlights
RXST's gross profit has soared by 117% YoY and by 19% from the previous quarter
RXST's equity has surged by 75% year-on-year and by 68% since the previous quarter
Key stats
What are the main financial stats of RXST
Market
Valuations
Earnings
Shares outstanding
39.68M
Market cap
$1.92B
Enterprise value
$1.91B
Price to earnings (P/E)
N/A
Price to book (P/B)
6.55
Price to sales (P/S)
16.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.58
Revenue
$115.18M
EBIT
-$36.51M
EBITDA
-$32.33M
Free cash flow
-$35.35M
Per share
Balance sheet
Liquidity
EPS
-$1.01
Free cash flow per share
-$0.92
Book value per share
$7.4
Revenue per share
$3
TBVPS
$7.94
Total assets
$305.5M
Total liabilities
$30.29M
Debt
$11.41M
Equity
$275.21M
Working capital
$261.61M
Debt to equity
0.04
Current ratio
14.33
Quick ratio
13.24
Net debt/EBITDA
0.43
Margins
Efficiency
Dividend
EBITDA margin
-28.1%
Gross margin
66.3%
Net margin
-31.9%
Operating margin
-36.8%
Return on assets
-17.2%
Return on equity
-19.3%
Return on invested capital
-20.4%
Return on capital employed
-12.8%
Return on sales
-31.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RXST stock price
How has the RxSight stock price performed over time
Intraday
-3.6%
1 week
-4.3%
1 month
-5.97%
1 year
102%
YTD
20.24%
QTD
-1.92%
Financial performance
How have RxSight's revenue and profit performed over time
Revenue
$115.18M
Gross profit
$76.32M
Operating income
-$42.37M
Net income
-$36.77M
Gross margin
66.3%
Net margin
-31.9%
RXST's gross profit has soared by 117% YoY and by 19% from the previous quarter
RXST's revenue has surged by 72% year-on-year and by 14% since the previous quarter
RxSight's net margin has soared by 64% YoY and by 28% from the previous quarter
The company's operating margin has surged by 57% YoY and by 22% QoQ
Growth
What is RxSight's growth rate over time
Valuation
What is RxSight stock price valuation
P/E
N/A
P/B
6.55
P/S
16.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.58
The EPS has grown by 49% year-on-year and by 19% since the previous quarter
RXST's equity has surged by 75% year-on-year and by 68% since the previous quarter
RXST's P/B is 22% below its last 4 quarters average of 8.7
RXST's revenue has surged by 72% year-on-year and by 14% since the previous quarter
Efficiency
How efficient is RxSight business performance
RXST's ROE has soared by 60% YoY and by 30% QoQ
The return on sales has surged by 60% year-on-year and by 25% since the previous quarter
The ROA has increased by 49% YoY and by 28% from the previous quarter
RxSight's return on invested capital has increased by 28% YoY and by 24% QoQ
Dividends
What is RXST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RXST.
Financial health
How did RxSight financials performed over time
The total assets has surged by 67% since the previous quarter and by 56% year-on-year
RxSight's quick ratio has soared by 64% from the previous quarter and by 36% YoY
RxSight's debt is 96% less than its equity
RXST's debt to equity has surged by 100% since the previous quarter but it has dropped by 73% year-on-year
RXST's equity has surged by 75% year-on-year and by 68% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.